1. Home
  2. LI vs VTR Comparison

LI vs VTR Comparison

Compare LI & VTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Li Auto Inc.

LI

Li Auto Inc.

HOLD

Current Price

$17.06

Market Cap

28.5B

ML Signal

HOLD

Logo Ventas Inc.

VTR

Ventas Inc.

HOLD

Current Price

$77.79

Market Cap

36.3B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
LI
VTR
Founded
2015
1983
Country
China
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Real Estate Investment Trusts
Sector
Consumer Discretionary
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
28.5B
36.3B
IPO Year
2020
1998

Fundamental Metrics

Financial Performance
Metric
LI
VTR
Price
$17.06
$77.79
Analyst Decision
Hold
Buy
Analyst Count
8
14
Target Price
$20.91
$78.43
AVG Volume (30 Days)
4.8M
3.2M
Earning Date
11-26-2025
10-29-2025
Dividend Yield
N/A
2.47%
EPS Growth
N/A
N/A
EPS
0.62
0.53
Revenue
$17,952,966,790.00
$5,544,046,000.00
Revenue This Year
N/A
$17.34
Revenue Next Year
$26.73
$10.07
P/E Ratio
$27.50
$147.59
Revenue Growth
N/A
16.38
52 Week Low
$16.77
$56.68
52 Week High
$33.12
$81.89

Technical Indicators

Market Signals
Indicator
LI
VTR
Relative Strength Index (RSI) 28.65 49.65
Support Level $16.77 $76.14
Resistance Level $18.04 $81.89
Average True Range (ATR) 0.43 1.38
MACD 0.05 -0.62
Stochastic Oscillator 12.58 30.35

Price Performance

Historical Comparison
LI
VTR

About LI Li Auto Inc.

Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.

About VTR Ventas Inc.

Ventas owns a diversified healthcare portfolio of almost 1,400 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Share on Social Networks: